TY  - GEN
AU  - Im,S H
AU  - Barchan,D
AU  - Maiti,P K
AU  - Raveh,L
AU  - Souroujon,M C
AU  - Fuchs,S
TI  - Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18
SN  - 1530-6860
PY  - 2001///1204
KW  - Abatacept
KW  - Animals
KW  - Antibodies
KW  - therapeutic use
KW  - Antigens, CD
KW  - Antigens, Differentiation
KW  - biosynthesis
KW  - B-Lymphocytes
KW  - immunology
KW  - CD40 Ligand
KW  - metabolism
KW  - CTLA-4 Antigen
KW  - Cells, Cultured
KW  - Cytokines
KW  - Disease Progression
KW  - Female
KW  - Hypersensitivity, Delayed
KW  - therapy
KW  - Immunoconjugates
KW  - Immunoglobulin G
KW  - Interleukin-18
KW  - antagonists & inhibitors
KW  - Kinetics
KW  - Lymphocyte Activation
KW  - Myasthenia Gravis, Autoimmune, Experimental
KW  - Rats
KW  - Rats, Inbred Lew
KW  - Receptors, Nicotinic
KW  - T-Lymphocytes
KW  - Th1 Cells
KW  - Transforming Growth Factor beta
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1096/fj.01-0072com
ER  -